Should we test for genotype in deciding on age-related eye disease study supplementation?

scientific article published on 01 January 2015

Should we test for genotype in deciding on age-related eye disease study supplementation? is …
instance of (P31):
scholarly articleQ13442814
editorialQ871232

External links are
P356DOI10.1016/J.OPHTHA.2014.10.023
P698PubMed publication ID25542537

P2093author name stringJanet Wittes
David C Musch
P433issue1
P921main subjecteye diseaseQ3041498
P304page(s)3-5
P577publication date2015-01-01
P1433published inOphthalmologyQ7098109
P1476titleShould we test for genotype in deciding on age-related eye disease study supplementation?
P478volume122

Reverse relations

cites work (P2860)
Q47567166CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation
Q47793048Genetic Polymorphisms of CFH and ARMS2 Do Not Predict Response to Antioxidants and Zinc in Patients with Age-Related Macular Degeneration: Independent Statistical Evaluations of Data from the Age-Related Eye Disease Study
Q26738526Genetics and age-related macular degeneration: a practical review for the clinician
Q38800270Nutrition, Genes, and Age-Related Macular Degeneration: What Have We Learned from the Trials?
Q38510019Pharmacogenetics and nutritional supplementation in age-related macular degeneration
Q36992469Serum molecular signature for proliferative diabetic retinopathy in Saudi patients with type 2 diabetes

Search more.